STOK — Stoke Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Stoke Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	287	220	230	201	217
Net Total Receivables	0.006	0.132	0.588	0.064	0.7
Prepaid Expenses
Total Other Current Assets
Total Current Assets	294	229	244	215	233
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.79	9.08	11.4	12.4	8.25
Long Term Investments
Other Long Term Assets
Total Assets	298	239	256	228	272
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	11.4	17.1	31.4	30.8	40.1
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	11.8	21.1	71.2	68.8	42.5
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	286	218	185	160	229
Total Liabilities & Shareholders' Equity	298	239	256	228	272
Total Common Shares Outstanding